Migraine Headache Protocol

Neurological HealthModerate Evidence

supplements

Primary

Supporting

Grade A

Studies

Primary Stack

Core supplements with strongest evidence

MagnesiumA

400-600mg daily (citrate, glycinate, or oxide)

Deficiency common in migraineurs; supplementation reduces frequency and severity by stabilizing neurovascular function

Cramps↓Migraine Severity↓Migraine Frequency↓Migraine Duration↑Pre-Eclampsia Risk

25 studies1,500 participants

Supporting Studies (2)

PMID: 26655854 - Magnesium for migraine prophylaxis: systematic review (2016)PMID: 27770009 - Magnesium in migraine prevention: meta-analysis (2016)

Riboflavin (Vitamin B2)A

400mg daily

Supports mitochondrial energy production; high-dose supplementation significantly reduces migraine frequency

Migraine FrequencyMigraine Duration↓Migraine Severity

15 studies800 participants

Supporting Studies (2)

PMID: 15447697 - Riboflavin 400mg for migraine prevention: RCT (2004)PMID: 28931395 - Riboflavin for migraine: systematic review (2017)

Supporting Stack

Additional supplements for enhanced results

Coenzyme Q10B

100-300mg daily

Supports mitochondrial function; reduces migraine frequency by improving brain energy metabolism

↓Calcitonin Gene-related Peptide↓Migraine Duration↓Migraine Frequency↓Migraine Severity↓Nausea Symptoms

12 studies600 participants

Supporting Studies (1)

PMID: 27412618 - CoQ10 for migraine prevention: systematic review (2016)

Vitamin DB

2000-4000 IU daily (based on blood levels)

Deficiency associated with migraine; supplementation may reduce frequency through anti-inflammatory effects

↓Migraine Frequency↓Migraine Severity

10 studies500 participants

Supporting Studies (1)

PMID: 30050864 - Vitamin D for migraine prophylaxis: systematic review (2018)

FeverfewB

50-150mg daily (standardized to parthenolide)

Traditional herb that inhibits prostaglandins and serotonin release from platelets; reduces frequency and severity

Migraine FrequencyMigraine Duration↓Migraine Severity

10 studies500 participants

Supporting Studies (1)

PMID: 25916335 - Feverfew for migraine prevention: Cochrane review (2015)

ButterburB

50-75mg twice daily (PA-free extract only)

Anti-inflammatory and antispasmodic; significantly reduces migraine frequency (must be PA-free)

↓Migraine Frequency

8 studies400 participants

Supporting Studies (1)

PMID: 16251963 - Butterbur for migraine prevention: systematic review (2005)

Fish Oil (Omega-3)C

2-4g EPA/DHA daily

Anti-inflammatory effects may reduce neurogenic inflammation involved in migraine pathophysiology

↓Migraine Frequency↓TNF-Alpha

8 studies400 participants

Supporting Studies (1)

PMID: 33984294 - Omega-3 for migraine: RCT (2021)

MelatoninC

3mg at bedtime

Regulates circadian rhythm and has anti-inflammatory effects; may reduce migraine frequency

↓Insomnia Signs and Symptoms↓Migraine Frequency↓Migraine Duration↓Migraine Severity↑Sleep Quality

8 studies400 participants

Supporting Studies (1)

PMID: 28049067 - Melatonin for migraine prevention: systematic review (2017)

How This Protocol Works

Simple Explanation

Migraines are a neurological condition characterized by recurring episodes of severe, often one-sided headache, typically accompanied by nausea, vomiting, and sensitivity to light and sound. Some people also experience aura (visual disturbances, tingling) before the headache. Migraines involve abnormal brain activity, blood vessel changes, and inflammation. While acute treatments stop individual attacks, prevention (reducing frequency and severity) is the goal for those with frequent migraines.

IMPORTANT: New or changed headache patterns should be evaluated by a healthcare provider. These supplements are for prevention, not acute treatment. Prescription medications may be needed for frequent or severe migraines.

•Magnesium deficiency is found in up to 50% of migraine sufferers. Magnesium plays crucial roles in neurotransmitter release, blood vessel tone, and inflammation. Studies consistently show that supplementation reduces migraine frequency by about 40%. It's particularly helpful for menstrual migraines. The American Academy of Neurology and American Headache Society recognize it as 'probably effective' for prevention.

•Riboflavin (Vitamin B2) at high doses (400mg—much more than in typical multivitamins) supports mitochondrial energy production. Migraines may involve mitochondrial dysfunction in brain cells. Studies show 400mg daily can reduce migraine frequency by about 50% after 3 months. It's very safe with minimal side effects (bright yellow urine is normal).

•Coenzyme Q10 also supports mitochondrial function. Studies in both adults and children show it can reduce migraine frequency. It works synergistically with riboflavin since both support mitochondrial energy production.

•Vitamin D deficiency is more common in migraine sufferers, and supplementation may help reduce frequency, possibly through anti-inflammatory effects. Get your levels tested and supplement accordingly.

•Feverfew is a traditional herb used for centuries for headaches. It contains parthenolide, which inhibits prostaglandins and prevents serotonin release from platelets (both involved in migraines). While studies show mixed results, it has a good safety profile for long-term use.

•Butterbur (Petasites hybridus) showed impressive results in clinical trials, reducing migraine frequency by about 50%. However, it must be a PA-free (pyrrolizidine alkaloid-free) extract, as PAs can cause liver damage. Due to safety concerns, some countries have restricted its sale.

•Fish Oil (Omega-3) has anti-inflammatory effects that may reduce neurogenic inflammation in migraines. A recent study found that high-EPA fish oil significantly reduced migraine days compared to a high-omega-6 diet.

•Melatonin may help by regulating circadian rhythms (migraines often have circadian patterns) and through anti-inflammatory effects. Studies suggest 3mg at bedtime may reduce frequency.

Expected timeline: Migraine prevention requires consistent daily use for 2-3 months before judging effectiveness. Magnesium: 4-12 weeks. Riboflavin: 3 months for full effect. CoQ10: 2-3 months. Keep a headache diary to track frequency.

Clinical Perspective

Migraine is a primary headache disorder characterized by recurrent moderate-severe headaches lasting 4-72 hours with associated features (nausea/vomiting, photophobia, phonophobia) and disability. Pathophysiology involves trigeminovascular activation, cortical spreading depression (in migraine with aura), calcitonin gene-related peptide (CGRP) release, and neurogenic inflammation. Mitochondrial dysfunction and oxidative stress may contribute. Prevention indicated when ≥4 migraine days/month or significant disability.

•Magnesium (A-grade): Modulates NMDA receptor, serotonin receptors, and nitric oxide synthesis. Prevents cortical spreading depression. 30-50% of migraineurs have deficiency. Systematic review: reduces attack frequency and severity (PMID: 26655854). Meta-analysis confirms prophylactic efficacy (PMID: 27770009). AAN/AHS Level B evidence (probably effective). 400-600mg/day; magnesium oxide most studied but citrate/glycinate better tolerated. IV magnesium used for acute severe migraine.

•Riboflavin (Vitamin B2) (A-grade): Precursor to FAD, essential for mitochondrial electron transport chain. Addresses mitochondrial dysfunction hypothesis. RCT: 400mg/day reduced migraine frequency 50% vs 15% placebo (PMID: 15447697). Systematic review confirms efficacy (PMID: 28931395). AAN/AHS Level B evidence. 400mg/day; takes 3 months for full effect. Bright yellow urine is harmless.

•Coenzyme Q10 (B-grade): Mitochondrial electron carrier, supports ATP synthesis. Systematic review: reduces migraine frequency, particularly in pediatric populations (PMID: 27412618). Often combined with riboflavin and magnesium ('mito cocktail'). 100-300mg/day. Well-tolerated.

•Vitamin D (B-grade): Deficiency prevalent in migraineurs. Vitamin D has anti-inflammatory and immunomodulatory effects. Systematic review: supplementation associated with reduced frequency, though heterogeneous data (PMID: 30050864). Target 25(OH)D >40 ng/mL. 2000-4000 IU/day based on baseline.

•Feverfew (Tanacetum parthenium) (B-grade): Parthenolide inhibits prostaglandin synthesis, serotonin release from platelets, and NF-κB. Traditional use for migraine. Cochrane review: modest evidence supports efficacy; variability in preparations affects outcomes (PMID: 25916335). 50-150mg/day standardized to 0.2-0.4% parthenolide. Gradual withdrawal recommended.

•Butterbur (Petasites hybridus) (B-grade): Petasins have anti-inflammatory and antispasmodic effects. Systematic review: 50-75mg twice daily reduced frequency by ~50% (PMID: 16251963). AAN Level A evidence. CRITICAL: Only use PA-free (pyrrolizidine alkaloid-free) extracts—PAs are hepatotoxic and carcinogenic. Petadolex brand studied. Availability limited due to safety concerns.

•Fish Oil (Omega-3) (C-grade): EPA/DHA compete with arachidonic acid, reducing pro-inflammatory eicosanoid synthesis. Recent RCT: high-EPA diet significantly reduced migraine days compared to control (PMID: 33984294). May work through resolvins and reduced neurogenic inflammation. 2-4g/day EPA/DHA.

•Melatonin (C-grade): Regulates circadian rhythm, has anti-inflammatory and antioxidant effects, may modulate CGRP. Systematic review: 3mg at bedtime may reduce frequency, comparable to some conventional prophylactics (PMID: 28049067). Particularly relevant if sleep dysfunction contributes.

Biomarker targets: Migraine diary (frequency, severity, duration, disability), MIDAS (Migraine Disability Assessment), HIT-6 (Headache Impact Test), serum magnesium (often normal even in deficiency—RBC magnesium more accurate), 25(OH)D, ionized calcium if hypomagnesemia.

Protocol notes: Identify and avoid triggers (dietary, hormonal, stress, sleep disruption, weather). Regular sleep schedule essential. Regular aerobic exercise reduces frequency. Stay hydrated. Limit caffeine (though abrupt withdrawal triggers headaches). Avoid medication overuse headache (>10 days/month acute medication use). Prescription prevention: beta-blockers (propranolol, metoprolol), antidepressants (amitriptyline, venlafaxine), anticonvulsants (topiramate, valproate), CGRP inhibitors (erenumab, fremanezumab). Botox for chronic migraine (≥15 days/month). Neuromodulation devices (Cefaly, gammaCore). Behavioral therapies (biofeedback, relaxation, CBT). Menstrual migraine: perimenstrual prevention strategies.

View All Protocols